Related Experiment Video
Updated: May 15, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients
Michela Faggioni1, Hyun Seok Hwang, Christian van der Werf
1Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232-0575, USA.
Rationale:
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is caused by mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes. Sinoatrial node dysfunction associated with CPVT may increase the risk for ventricular arrhythmia (VA).
Objective:
To test the hypothesis that CPVT is suppressed by supraventricular overdrive stimulation.
Methods And Results:
Using CPVT mouse models (Casq2(-/-) and RyR2(R4496C/+) mice), the effect of increasing sinus heart rate was tested by pretreatment with atropine and by atrial overdrive pacing. Increasing intrinsic sinus rate with atropine before catecholamine challenge suppressed ventricular tachycardia in 86% of Casq2(-/-) mice (6/7) and significantly reduced the VA score (atropine: 0.6±0.2 versus vehicle: 1.7±0.3; P<0.05). Atrial overdrive pacing completely prevented VA in 16 of 19 (84%) Casq2(-/-) and in 7 of 8 (88%) RyR2(R4496C/+) mice and significantly reduced ventricular premature beats in both CPVT models (P<0.05). Rapid pacing also prevented spontaneous calcium waves and triggered beats in isolated CPVT myocytes. In humans, heart rate dependence of CPVT was evaluated by screening a CPVT patient registry for antiarrhythmic drug-naïve individuals that reached >85% of their maximum-predicted heart rate during exercise testing. All 18 CPVT patients who fulfilled the inclusion criteria exhibited VA before reaching 87% of maximum heart rate. In 6 CPVT patients (33%), VA were paradoxically suppressed as sinus heart rates increased further with continued exercise.
Conclusions:
Accelerated supraventricular rates suppress VAs in 2 CPVT mouse models and in a subset of CPVT patients. Hypothetically, atrial overdrive pacing may be a therapy for preventing exercise-induced ventricular tachycardia in treatment-refractory CPVT patients.
Insights
Supraventricular overdrive stimulation, like atrial pacing, can suppress ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia (CPVT) mouse models. This approach also showed promise in a subset of human CPVT patients, suggesting a potential therapy for exercise-induced ventricular tachycardia.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a genetic disorder linked to mutations in cardiac ryanodine receptor (RyR2) or calsequestrin (Casq2) genes.
- Sinoatrial node dysfunction in CPVT patients may elevate the risk of ventricular arrhythmias (VA).
- Understanding the relationship between heart rate and VA is crucial for managing CPVT.
Purpose of the Study:
- To investigate whether supraventricular overdrive stimulation can suppress ventricular arrhythmias in CPVT.
- To evaluate the efficacy of increasing sinus heart rate as a potential antiarrhythmic strategy for CPVT.
Main Methods:
- Utilized CPVT mouse models (Casq2(-/-) and RyR2(R4496C/+)) to assess the impact of atropine and atrial overdrive pacing on ventricular tachycardia.
- Measured ventricular arrhythmias, premature beats, and spontaneous calcium waves in isolated myocytes.
- Analyzed heart rate dependence of CPVT in drug-naïve human patients during exercise testing.
Main Results:
- Atropine and atrial overdrive pacing significantly suppressed ventricular arrhythmias in CPVT mouse models.
- Rapid pacing prevented triggered beats and calcium waves in isolated CPVT myocytes.
- In humans, a subset of CPVT patients experienced paradoxical suppression of VA as heart rates increased during exercise.
Conclusions:
- Accelerated supraventricular rates demonstrate a suppressive effect on ventricular arrhythmias in CPVT mouse models.
- Findings suggest that atrial overdrive pacing could be a therapeutic strategy for exercise-induced ventricular tachycardia in refractory CPVT patients.
- Heart rate modulation represents a promising avenue for managing CPVT.
Related Concept Videos
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Dysrhythmias VI: Management of Dysrhythmias
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

